Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 8.01
The filing discloses a material update on a pending merger: Esperion entered into a Merger Agreement with ArchiMed SAS affiliates on May 1, 2026, and on June 8, 2026, received clearance from the German antitrust authority (Bundeskartellamt). The disclosure explicitly states the Merger remains subject to HSR clearance and stockholder approval at a special meeting scheduled for July 8, 2026. This is a significant M&A milestone that would materially affect investor assessment of the company's future.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 1.01
The filing discloses entry into a material definitive agreement for the acquisition of a commercial real property (16,100 sq ft automotive service building in Kansas) for $5.8 million, with closing expected within 45 days. This is a classic Item 1.01 material acquisition event. The Company's plan to assign interests to a Delaware statutory trust and raise capital through a private placement of beneficial interests further confirms the materiality of this transaction to investors assessing the registrant's asset base and capital structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses an amended and restated employment agreement for Ms. Cindy Lee, the Chief Financial Officer, detailing her base salary ($500,000), discretionary bonus eligibility, a special long-term equity award of 20,000 RSUs vesting over three years, severance provisions including change-of-control protections (2.5x base salary plus bonus), and benefits continuation. This is a material compensatory arrangement for a named executive officer that would affect investor assessment of executive costs and retention incentives.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 8.01
The disclosure announces receipt of all regulatory approvals for a merger of Signature Bancorporation into Esquire Financial Holdings. This represents a material acquisition/change of control event—the completion of regulatory approval is a critical milestone in M&A activity that would materially affect investor assessment of the registrant's future operations and financial position.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-09
Item 5.02
Christopher M. Miller (EVP, CFO) departed effective June 26, 2026, and Matthew P. Delly (EVP, Chief Merchandising & Purchasing Officer) departed effective June 12, 2026. These departures of two senior executives represent material changes to the company's management structure and financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 7.01
Paul Miller was appointed Executive Vice President, Chief Purchasing and Merchandising Officer, effective June 9, 2026, bringing 25 years of tenure with the company in progressively senior roles. This appointment fills a critical C-suite position overseeing merchandising and purchasing functions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Alexis Black Björlin as a member of the Board of Directors on June 9, 2026. While the section also mentions her compensation arrangement under the 2025 Director Compensation Plan, the principal disclosed action is her appointment to the Board and assignment to the Governance and Sustainability Committee. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-09
Item 5.02
Dr. Ranbir Singh resigned from the Board of Directors effective immediately on June 9, 2026, after serving since November 2024. At the time of resignation, he held the position of Chair of the Executive Steering Committee, a senior board role. The filing's reference to his prior Schedule 13D filings (April 23 and May 29, 2026) suggests potential activist involvement or governance concerns, making this departure material to investors' assessment of the company's board composition and control dynamics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing Cracker Barrel's fiscal 2026 third quarter results of operations and projected outlook for fiscal year 2026, filed under Item 2.02. This is a standard earnings release disclosure, which is material to investors as it provides quarterly financial performance and forward guidance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
Item 5.07
Humacyte held its Annual Meeting on June 9, 2026, where stockholders voted on and approved five proposals: election of three Class II directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, ratification of PwC as independent auditor, and approval of an amendment to increase authorized common shares from 350 million to 550 million.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from the June 8, 2026 annual meeting of Franklin BSP Realty Trust, Inc., covering three proposals: election of six directors, ratification of PwC as independent auditor, and an advisory vote on named executive officer compensation. The filing presents detailed voting tallies for each proposal, which is the core content of Item 5.07 disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from ClearSign's June 8, 2026 annual meeting. The filing presents detailed voting tallies for five proposals: election of four directors, appointment of auditor BPM CPA LLP, approval of the amended 2021 Equity Incentive Plan, advisory vote on named executive officer compensation, and approval of an adjournment proposal. All proposals passed. This is material as it documents the outcomes of fundamental corporate governance matters including board composition and equity plan authorization.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
Simon Property Group announced a €500 million debt offering by its subsidiary Simon Global Development B.V., priced at 3.650% due 2031, guaranteed by the parent company. While this is a material financing event affecting the registrant's capital structure and leverage, it does not fit cleanly into the standard taxonomy categories (not M&A, not a restatement, not a covenant breach, etc.). The disclosure is material to investors assessing the company's financial position and debt obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Shareholders voted at the Company's Annual Meeting on June 9, 2026, approving five proposals: election of five directors, ratification of BDO USA P.C. as auditor, approval of the 2026 Omnibus Incentive Plan, an advisory vote on named executive officer compensation, and an advisory vote on compensation vote frequency.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an annual meeting of stockholders held on June 3, 2026. The filing presents voting results for two proposals: (1) election of Class II directors (Sashi Brown and Jamila Mayfield, each receiving 21,530,729 votes for and 0 against), and (2) ratification of Ernst & Young LLP as independent auditor (21,530,729 for, 0 against, 1,138,021 abstentions). Director elections and auditor ratifications are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-09
Item 4.01
Vireo Growth Inc. dismissed Davidson & Company LLP as its independent registered public accounting firm effective June 5, 2026, and concurrently appointed BDO USA, P.C. as the new auditor. The filing indicates no disagreements or reportable events in connection with the transition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder voting results from the June 5, 2026 Annual Meeting of Stockholders, filed under Item 5.07. The filing presents final voting tallies for four proposals: election of six directors, ratification of Deloitte and Touche LLP as auditor, advisory approval of named executive officer compensation, and amendment to the 2018 Omnibus Equity Incentive Plan. All proposals were approved. This is a material event as it reflects stockholder decisions on governance, auditor selection, and equity plan authorization.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Ulta Beauty held its Annual Meeting of Stockholders on June 9, 2026, with shareholders voting on six proposals: election of ten directors, approval of exculpation and forum selection amendments to the certificate of incorporation, ratification of Ernst & Young LLP as auditor, an advisory vote on executive compensation, and approval of the 2026 Incentive Award Plan.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-06-09
Item 5.02
Stockholders approved the 2026 Incentive Award Plan, which replaces the prior equity compensation plan and authorizes 5,001,201 shares for future grants of stock options, RSUs, restricted stock, and other equity awards to employees, consultants, and directors.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
Eagle Point Income Company Inc. disclosed management's unaudited estimate of net asset value (NAV) per share as of May 31, 2026, ranging from $12.52 to $12.62. For a closed-end investment company, NAV disclosure is material to investors assessing the fund's value and performance, though this appears to be a routine periodic NAV estimate rather than a discrete material event. Classified as other_material because NAV disclosure does not fit the more specific event categories, but it is material to shareholders of an income-focused investment company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
Item 5.02
The filing discloses the appointment of Donna T. Guerra to the Board of Directors of Fifth District Bancorp, Inc. and its bank subsidiary effective June 8, 2026. The principal action is a person taking a director role, with detailed background information provided on her qualifications, including prior CFO and COO experience at Hibernia Bank. Board appointments are material events affecting corporate governance and investor assessment of the company.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
Eagle Point Credit Co disclosed management's unaudited estimate of net asset value (NAV) per share as of May 31, 2026, ranging from $4.55 to $4.65. For a closed-end credit company, NAV is a key metric affecting investor valuation and pricing decisions. While this appears to be a routine periodic NAV disclosure under Item 8.01, it is material to shareholders as it directly informs the fair value of their holdings. This does not fit neatly into other specific event categories but warrants classification as material disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-09
Item 5.02
Stephen M. Cook, a Class II director and Chair of the Nominating and Corporate Governance Committee, notified the Board that he will not stand for re-election at the 2026 Annual Meeting, with his retirement effective upon expiration of his current term.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
Item 8.01
The Board unanimously approved Todd C. Harvey as a new Class II director nominee for the 2026 Annual Meeting, subject to stockholder election, representing a material change in board composition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
Item 1.01
Hut 8 Corp., through its wholly-owned subsidiary Beacon Point DC LLC, completed a $4.25 billion senior secured notes offering on June 9, 2026, with proceeds earmarked to finance a 352 MW data center facility in Texas to be leased to a high-investment-grade tenant. This material capital structure event and significant operational commitment affects the company's financial position and strategic direction.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
The Board approved a $40 million stock repurchase program on May 13, 2026, which is a material capital allocation decision affecting shareholder value and the company's financial strategy. While share repurchases are common corporate actions, a $40 million authorization is material to investors assessing capital deployment and future earnings per share impacts. This does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or impairment), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 7.01
Cartesian Therapeutics disclosed entry into a strategic licensing agreement with WestGene Biopharma for development of novel in vivo CAR-T therapies in autoimmune diseases. While this is a material partnership/licensing arrangement that could affect the company's pipeline and strategic direction, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The licensing agreement is a material collaboration event that a reasonable investor would want to know about, but lacks the acquisition/merger/control-change characteristics of ma_activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-09
Item 1.01
This disclosure concerns an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending key deadlines (tender offer commencement from June 1 to June 10, 2026, and the Outside Date from July 1 to July 17, 2026) and modifying payment obligations and waivers. The amendment directly relates to the ongoing merger transaction and materially affects its timing and conditions, making it a material M&A activity event under Item 1.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-09
Item 7.01
Allegiant Travel completed the acquisition of Sun Country Airlines Holdings, Inc., financed in part through approximately $224.7 million in aircraft financing transactions completed between April and May 2026. Pro forma financial information reflecting the combined entity's capital structure and financial position was disclosed.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-09
Item 8.01
Allegiant Travel commenced a $500 million private offering of senior secured notes due 2031 to qualified institutional buyers under Rule 144A and Regulation S, concurrent with a tender offer for $403 million of existing 2027 notes.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-06-09
Item 8.01
The disclosure reports that CarParts.com has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5450(a)(1)) after the closing bid price remained at $1.00 or greater for 10 consecutive business days. This is a delisting-risk event because it documents resolution of a prior non-compliance notice that threatened continued listing. The materiality is high because listing status directly affects investor access and trading liquidity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 3.02
The filing discloses two unregistered equity issuances: (1) 398,666 shares issued as consideration for the Lyphe Group acquisition under Section 4(a)(2), and (2) 1,214,186 shares issued in a debt-for-equity exchange under Section 3(a)(9). Together, these represent approximately 1.6 million shares of dilutive issuance, with the debt exchange alone converting $6 million of convertible notes. This is material to investors as it increases share count and dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-09
Item 8.01
Allegiant Travel announced a private offering of $650.0 million in Senior Secured Notes due 2031, increased from the previously announced $500.0 million. The offering is being conducted under Rule 144A and Regulation S as an unregistered private placement to qualified institutional buyers and non-U.S. persons. While technically debt rather than equity, this represents a material capital-raising transaction that increases the company's financial obligations and would affect a reasonable investor's assessment of leverage and financial structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-09
Item 7.01
The company announced the immediate departure of two senior executives: Greg Dale (Chief Operating Officer) and Frank Friedman (Head of Measurement and Chief Data and Analytics Officer). Their responsibilities are being assumed by the CEO.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-09
Item 8.01
The filing discloses a press release issued on June 9, 2026, but the actual content of the press release is not provided in the Item 8.01 text itself—only a reference to Exhibit 99.1. Without access to the exhibit content, the specific nature of the material event cannot be determined. Given that it is disclosed under Item 8.01 (Other Events) and involves a press release, it is likely material, but the event type cannot be confidently classified into a more specific category (e.g., earnings_release, material_litigation, going_concern) without knowing the press release's subject matter.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-09
Item 8.01
The filing discloses a press release issued on June 9, 2026, but the actual content of the press release is not provided in the Item 8.01 text itself—only a reference to Exhibit 99.1. Without access to the exhibit content, the specific nature of the announcement cannot be determined. Given the Item 8.01 classification (Other Events) and the presence of a press release, this is likely material, but the event type cannot be confidently assigned to a more specific category without knowing what the press release announces.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 8.01
The filing discloses updated risk factors relating to the Company's expansion into GPU computing infrastructure ownership and operation. While Item 8.01 is used for miscellaneous disclosures, the explicit statement that updated risk factors "supersede" prior disclosures and the material nature of the business expansion (GPU data center infrastructure) suggest this is a material event that does not fit neatly into more specific categories. The disclosure appears designed to inform investors of newly material risks associated with a significant business line expansion.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-09
Item 1.01
Novanta Inc. entered into an Equity Purchase Agreement on June 8, 2026, to acquire all issued and outstanding interests of Runway Buyer for $1.2 billion in closing consideration plus a $250 million milestone payment, subject to HSR approval and other regulatory conditions. The transaction was announced via press release on June 9, 2026, with forward-looking statements addressing expected timing, completion, anticipated synergies, and integration risks.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
Lands' End disclosed financial results for the first quarter ended May 1, 2026, furnished as a press release exhibit. This is a standard quarterly earnings announcement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-06-09
Item 1.01
Nuvalent entered into an Agreement and Plan of Merger with GlaxoSmithKline LLC on June 9, 2026, whereby GSK will commence a tender offer at $124.00 per share, followed by a merger if conditions are satisfied. This is a material acquisition and change of control transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 8.01
The filing discloses a press release reporting AUM as of May 31, 2026, filed under Item 8.01 (Other Events). While AUM is a key operational metric for asset management firms, this disclosure does not fit the standard earnings_release category (which typically reports quarterly or annual financial results with comprehensive income statement and balance sheet data). The filing appears to be a standalone AUM update rather than a full earnings release, making other_material the most appropriate classification, though the materiality depends on whether the AUM figures represent significant changes that would affect investor assessment of the company's business performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-09
Item 8.01
This Item 8.01 disclosure presents Mercury General's consolidated financial highlights for Q1 2026 and full-year 2025, including net premiums earned, net income, and operating income figures. The filing includes detailed financial tables comparing Q1 2026 to Q1 2025 and full-year 2025 to 2024, along with reconciliations to GAAP measures. This constitutes a material earnings disclosure that would affect investor assessment of the company's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 95%
filed 2026-06-09
Item 8.01
The filing discloses a material cybersecurity incident at Evertec, a third-party core processing provider, affecting customer data of BPPR (Popular's Puerto Rico subsidiary). The compromised data includes personal information, debit card numbers, and other customer information. Although the Corporation states it does not currently believe the incident is reasonably likely to have material impact, the disclosure itself—involving customer data compromise, regulatory notification, and enhanced fraud monitoring—constitutes a material cybersecurity incident requiring 8-K disclosure under Item 1.05 rules (effective 2023).
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—describing the mechanics of consolidated obligation issuance, the joint and several liability structure, and the exclusions from Schedule A. The filing does not disclose a specific new debt covenant, acceleration clause, or cross-default trigger that would constitute a "covenant_breach" event. The materiality lies in the ongoing debt issuance program rather than a discrete triggering event, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 1.01
Sherwin-Williams entered into Amendment No. 11 to its credit facility, extending $200 million in credit commitments from June 2026 to June 2031. This material financing arrangement affects the company's liquidity and capital structure flexibility.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 7.01
The filing discloses an updated 2026 outlook following the acquisition of Thermon Group Holdings, Inc., issued via press release on June 9, 2026. While the acquisition itself would typically be classified as ma_activity, this Item 7.01 disclosure focuses on the forward guidance update rather than the acquisition event itself. The guidance update is material to investors assessing future performance, but the disclosure is furnished (not filed) under Regulation FD, and the core acquisition event likely appears elsewhere in the 8-K. This is best classified as other_material since it is a material forward-looking statement tied to a completed acquisition, but does not fit neatly into earnings_release (no historical results) or the ma_activity category (the acquisition is referenced as context, not as the primary disclosed event).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from the June 4, 2026 annual meeting of stockholders. The filing reports the final voting tallies for two proposals: (1) election of Wendell E. Pritchett as a Class III director with 18,436,266 votes for and zero against, and (2) ratification of Deloitte & Touche LLP as independent auditor with identical voting results. This is a routine but material Item 5.07 disclosure required by SEC rules for annual meeting outcomes.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
Item 1.01
PennantPark Private Income Fund entered into a second amendment to its senior secured revolving credit facility on June 5, 2026, increasing borrowing capacity from $120.0 million to $200.0 million. While this is a credit facility amendment rather than a traditional M&A transaction, it represents a material change to the registrant's financing structure and debt capacity, which would affect a reasonable investor's assessment of the company's liquidity and financial flexibility. The 67% increase in available borrowing capacity is a material financial event disclosed under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Verrica Pharmaceuticals held an Annual Meeting of Stockholders with four proposals: election of directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as auditor, and approval of the Amended and Restated 2018 Equity Incentive Plan. Vote results for all four proposals are disclosed with detailed tallies.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Shareholders voted at the June 3, 2026 Annual Meeting, approving four proposals: election of directors Donna Corley and Tela Mathias as Class II directors, ratification of Deloitte as independent auditor, advisory approval of named executive officer compensation, and approval of a reverse stock split amendment.
View raw filing on EDGAR →